Improving Global Outcomes (KDIGO) group has updated chronic kidney disease treatment guidelines to help slow disease progression in adults. A JAMA article published Wednesday summarized the revised ...

Atopic dermatitis (AD) was associated with an increased risk for chronic kidney disease (CKD) in an Asian population, ...

Gout management u2028in patients with CKD Each month, Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in ...

USA: In a significant stride towards enhancing the quality of care for individuals living with chronic kidney disease (CKD), the Kidney Disease: Improving Global Outcomes (KDIGO) initiative has ...

In the KDIGO announcement of the publication of the 2024 CKD guideline, Adeera Levin MD, one of the Guideline Committee Co-Chairs said, “ Recent advancements in GFR evaluation, risk prediction ...

The KDIGO guideline, specifically in Practice Points 1.1.4.1 and 1.1.4.2, states that genetic tests should be used, among other factors, to establish cause for CKD, and that genetic testing can ...

The updated guideline includes consensus statements supporting the use of genetic testing to establish the cause of chronic kidney disease (CKD) for a majority of patients with this condition.

In the release of the new guideline, timed to coincide with World Kidney Day on March 14, the KDIGO committee highlighted the role of risk prediction in guiding care for patients. In this context, ...

The Kidney Disease: Improving Global Outcomes (KDIGO) program has published a 2024 clinical practice guideline for the management of lupus nephritis (LN) in Kidney International and its supplements.

Medical experts discuss considerations for ESRD during CKD treatment as well as updated guidelines for treatment of chronic kidney disease.

The 2012 KDIGO guidelines for managing anemia in CKD patients can help. For CKD patients without anemia measure hemoglobin concentration when clinically indicated and then: 3 ...